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a b s t r a c t
Silver nanoparticles (AgNPs) were synthesised by reducing silver salts using NaBH4 followed by capping
with varying concentrations of ␤-cyclodextrin (␤-CD) and were physically characterised. Antibacterial
activity against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus was determined by
a microtitre well method. The AgNPs were spherical under transmission electron microscopy, whilst
dynamic light scattering showed average diameters of capped particles to be smaller (4–7 nm) than their
uncapped equivalents (17 nm). Capped particles demonstrated superior photostability when exposed to
intense ultraviolet radiation for 4 h as well as signiﬁcantly (P < 0.05) higher (up to 3.5-fold) antibacterial
activity. The inﬂuence of ␤-CD concentration was seen to delay bacterial growth, indicating that a Trojan
horse mechanism may be occurring owing to bacterial carbohydrate afﬁnity, thereby enhancing silver
ion absorption.
© 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

1. Introduction
The persistence of antibiotic-resistant bacteria has renewed
interest in the use of silver and silver-based compounds, including silver nanoparticles (AgNPs), as alternative antibacterial agents.
Such compounds can reduce infections in burns patients and
prevent bacterial colonisation of prostheses, catheters, dental
materials and human skin. The high thermal stability, low toxicity
to human cells and effective broad-spectrum antibacterial activity
of AgNPs [1] have been exploited in a range of commercial products.
There are several hypotheses to explain the antibacterial activity
of AgNPs. Their rapid breakdown releases ionic silver that inactivates vital bacterial enzymes by interacting with essential thiol
groups. Silver ions can inhibit bacterial DNA replication, damaging
bacterial cytoplasmic membranes, depleting levels of intracellular adenosine triphosphate (ATP) and causing cell death [2]. The
high speciﬁc surface-to-volume ratio of AgNPs increases their contact with microorganisms, promoting the dissolution of silver ions,
thereby improving biocidal effectiveness. The ability of AgNPs to
release silver ions is key to their antibacterial activity [3].
AgNPs can be synthesised in a number of ways, with borohydride reduction of silver salts being the most common.
Stabilisation is achieved using capping agents that bind to the
nanoparticle surface and improve stability and water solubility,
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which are essential to prevent aggregation; examples include
water-soluble polymers, oligosaccharides and polysaccharides,
sodium dodecyl sulphate (SDS) and sophorolipid (glycolipid)
[4].
Cyclodextrins (CDs) are a family of soluble, non-toxic molecules
consisting of 6, 7 or 8 d-glucopyranosyl residues (denoted as ␣-,
␤- and ␥-CDs, respectively) linked in cyclic structure by ␣-1,4 glycosidic bonds. They can form inclusion complexes incorporating
various molecular guests within their hollow, truncated coneshaped cavity structure, enabling them to be used as drug carriers
and enzyme mimics. Host–guest interaction has been attributed to
a combination of weak interactions such as van der Waals forces,
hydrogen bonding and hydrophobic interactions [5]. Of the three
cyclodextrins, ␤-CD, with an internal cavity diameter of 0.78 nm, is
the most widely used but is too small to entrap AgNPs and simply
binds via chemisorption to the nanoparticles through rim hydroxyl
groups.
Unmodiﬁed ␤-CD has been used to prepare silver and gold
nanoparticles in the presence of different reducing agents such
as ethanol, dimethylformamide, ethylene glycol and sodium citrate. Little has been published on the antimicrobial activity of
unmodiﬁed CDs, but modiﬁed ␤-CD (dimethylated ␤-CD) inhibited growth of Rhodococcus erythropolis and hydroxypropyl-␤-CD
was toxic for Mycoplasma capricolum and Acholeplasma laidlawii,
whilst methylated ␤-CD altered growth and cell envelope features
of Mycobacterium sp. [6].
The present work investigated AgNP synthesis using different concentrations of unmodiﬁed ␤-CD with NaBH4 as the
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reducing agent. AgNPs were characterised by ultraviolet–visible
(UV–Vis) spectrometry, Fourier transform infrared spectroscopy
(FT-IR), dynamic light scattering (DLS) and transmission electron microscopy (TEM). Antibacterial activities of uncapped
and ␤-CD-capped AgNPs against Gram-negative (Escherichia coli
and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus
aureus) bacteria were determined.

VT) at 37 ◦ C. Samples were tested in duplicate on each plate and
each plate was analysed in triplicate.
2.5. Data analysis
2.5.1. Percentage inhibition of growth
AgNP antibacterial activities were determined by calculating the
percentage inhibition of growth using the formula [7]:

2. Materials and methods
I% =
2.1. Synthesis of silver nanoparticles
Aqueous ␤-CD solutions (5, 10 and 20 mM) were stirred into
equal volumes of 2 mM AgNO3 for 15 min and equal volumes of icecold 20 mM NaBH4 were added. Resultant solutions were stabilised
by stirring (24 h). The ﬁnal molar ratios of ␤-CD:AgNO3 were 2.5,
5 and 10 to 1, respectively. A ␤-CD-free control was similarly prepared. All chemicals were purchased from Sigma-Aldrich (Dublin,
Ireland) and were used without further puriﬁcation.
2.2. Sample characterisation
UV–Vis absorption spectra of ␤-CD-capped AgNPs were
acquired in the 300–800 nm wavelength range using an
UV–Vis–NIR spectrophotometer (Perkin-Elmer Lambda 900;
Perkin-Elmer) operating at a resolution of 2 nm. FT-IR spectra
were measured in the 4000–400 cm−1 range with a resolution of
1 cm−1 using a Perkin-Elmer Spectrum GX instrument in transmission mode using potassium bromide (KBr) pellets prepared by
mixing KBr powder with AgNP solutions and then drying (24 h,
100 ◦ C). AgNP morphology was determined using a JEM-100CX II
transmission electron microscope (JEOL) operated at an accelerating voltage of 100 kV. Samples were drop-cast onto standard
Formvar-coated copper grids (200–300 nm) and then air dried. The
average particle size (hydrodynamic diameter) was determined at
25 ◦ C by DLS using a Malvern Zetasizer Nano instrument (Malvern
Instruments) equipped with a 4 mW He–Ne laser and measured
using an automatic mode with a scattering angle of 90◦ . Sample
photostability was determined by exposing solutions to an intense
UV source (Q-sun Xenon Test Chamber; Q-Lab) operating at
0.4 W/m2 (340 nm) for 1, 2, 3 and 4 h, respectively.
2.3. Bacterial strains and growth conditions
Gram-negative bacteria (E. coli ATCC 11229 and P. aeruginosa
ATCC 27852) and Gram-positive bacteria (S. aureus ATCC 25923)
were grown, subcultured and maintained on Mueller–Hinton agar
(Lab M) and stored at 4 ◦ C. For the experiment, a single colony of
each organism was inoculated into 10 mL of Mueller–Hinton broth
(MHB) and incubated overnight at 37 ◦ C with shaking at 200 rpm.
The optical density of the overnight culture was adjusted to that of a
0.5 McFarland standard [1.5 × 108 colony-forming units (CFU)/mL]
using a Densimat photometer (bioMérieux, France) and diluted
with MHB to give a ﬁnal working concentration of 1 × 106 CFU/mL.

(C18 − C0 ) − (T18 − T0 )
100
(C18 − C0 )

where I is the percentage inhibition of growth, C18 is the blankcompensated optical density at 600 nm (OD600 ) of the positive
control of the organism at 18 h, C0 is the blank-compensated OD600
of the positive control of the organism at 0 h, T18 is the negative
control-compensated OD600 of the organism in the presence of test
sample at 18 h, and T0 is the negative control-compensated OD600
of the organism in the presence of test sample at 0 h.
2.5.2. Kinetic measurement of bacterial growth
Bacterial concentrations in the presence of capped and
uncapped AgNPs were determined over time by measuring the
OD600 every 30 min following 30 s of agitation. Antibacterial kinetics was analysed graphically as a plot of contact time versus OD600 .
2.5.3. Statistical analysis
Statistical differences between multiple comparisons were
evaluated using analysis of variance (ANOVA) followed by least
signiﬁcant difference testing. All statistical analyses were carried
out using STATGRAPHICS centurion XV. A P-value of <0.05 was
considered statistically signiﬁcant.
3. Results and discussion
3.1. Characterisation of ˇ-cyclodextrin-capped silver
nanoparticles
All AgNPs showed a surface plasmon absorption band around
400 nm as expected for colloidal AgNPs, indicating roughly spherical nanoparticles, whilst solution absorbance intensities increased
with ␤-CD concentration. Since the intensity of the plasmon resonance band depends on particle size, shape, metallic material and
its surrounding environment, the number of particles cannot be
related linearly to the absorbance intensities [8].
3.2. Ultraviolet stability
On exposure to intense UV radiation the colour of uncapped
AgNPs became darker, with the absorbance peak becoming
14.05 nm broader (with respect to peak width at half maximum)
over time. There were no signiﬁcant changes in absorbance at the
higher ␤-CD concentrations, although at 5 mM it increased slightly.
This conﬁrmed that uncapped AgNPs continued to grow and/or
aggregate over time, whilst AgNPs capped at appropriate ␤-CD
concentrations exhibited good stability.

2.4. Antibacterial activity assay
3.3. Silver nanoparticle–ˇ-cyclodextrin binding
Antibacterial activities of capped and uncapped AgNPs of different silver concentrations were determined by a microtitre well
method [7]. Samples were doubly diluted in water (100 L) in
microtitre wells and bacteria (100 L; 106 CFU/mL) were added.
Negative (AgNPs 100 L + sterile MHB 100 L) and positive (sterile MHB 100 L + bacterial suspension 100 L) control wells and a
sterility control blank (sterile MHB 200 L) were included in each
assay. Plates were incubated (18 h) in a microtitre plate reader
(PowerWaveTM Microplate spectrophotometer; BioTek, Winooski,

FT-IR conﬁrmed ␤-CD binding to the AgNP surface. The free
␤-CD spectrum showed bands at 947 cm−1 (skeletal vibration
involving ␣ 1–4 linkage) and 756 cm−1 (ring breathing vibration),
whilst bands at 708 cm−1 and 579 cm−1 were assigned to pyranose
ring vibration [9]. Comparison of the spectra of 20 mM ␤-CDcapped AgNPs and free ␤-CD showed a decrease in the relative
intensities of transmittance bands at 947 cm−1 , 756 cm−1 , 708 cm−1
and 579 cm−1 and a suppression of the –OH vibrational band at
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Table 1
Percentage growth inhibition of Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus in the presence of uncapped and ␤-cyclodextrin (␤-CD)-capped (5, 10
and 20 mM) silver nanoparticles (AgNPs) containing different silver concentrationsa .
Microorganism

Sample

[Ag]
100 ppm

P. aeruginosa
P. aeruginosa
P. aeruginosa
P. aeruginosa
E. coli
E. coli
E. coli
E. coli
S. aureus
S. aureus
S. aureus
S. aureus

20 mM ␤-CD–AgNPs
10 mM ␤-CD–AgNPs
5 mM ␤-CD–AgNPs
Uncapped AgNPs
20 mM ␤-CD–AgNPs
10 mM ␤-CD–AgNPs
5 mM ␤-CD–AgNPs
Uncapped AgNPs
20 mM ␤-CD–AgNPs
10 mM ␤-CD–AgNPs
5 mM ␤-CD–AgNPs
Uncapped AgNPs

99.72
99.08
99.85
97.40
99.19
100
99.59
100
99.76
99.06
98.62
98.40

±
±
±
±
±
±
±
±
±
±
±
±

50 ppm
0.2
0.8
0.4
2.2
0.3
0
0.4
0
0.3
0.8
1.0
0.8

96.11
98.59
97.23
96.55
96.81
96.96
97.38
96.52
97.75
97.50
98.46
97.31

±
±
±
±
±
±
±
±
±
±
±
±

25 ppm
3.7
1.5
1.5
1.3
2.9
2.9
3.3
2.4
2.6
0.8
1.5
1.9

98.36
98.34
98.37
96.23
96.91
97.01
97.91
97.73
96.99
98.14
97.04
97.46

±
±
±
±
±
±
±
±
±
±
±
±

12.5 ppm
1.1
1.4
1.1
3.1
1.6
1.4
2.0
0.7
1.2
1.6
0.9
1.0

99.24
97.27
64.50
13.92
98.40
97.02
97.39
97.58
97.48
97.4
96.98
96.88

±
±
±
±
±
±
±
±
±
±
±
±

0.5
0.7
6.2
6.6
0.7
0.6
0.2
2.3
0.8
0.8
0.9
0.9

6.25 ppm

3.12 ppm

N/D
N/D
N/D
N/D
53.45 ± 4.8
43.66 ± 3.3
29.28 ± 10.9
22.75 ± 10.3
97.14 ± 0.9
93.97 ± 3.2
66.58 ± 12.8
59.50 ± 7.6

N/D
N/D
N/D
N/D
34.84 ± 5.8
20.09 ± 4.6
19.38 ± 3.2
17.3 ± 1.0
46.96 ± 14.6
26.68 ± 10.5
18.245 ± 6.3
16.97 ± 7.6

N/D, no growth inhibition detected.
a
All values are the mean ± standard deviation of two parallel experiments performed in triplicate.

3400 cm−1 , indicating deprotonation of the hydroxyl groups [10] at
the rim of the CD structure. This suggests that there is chemisorption between the CD molecules and AgNPs via the rim hydroxyl
groups. Sorption of CDs might be due to binding of the AgNPs to
hydroxyl groups at positions C2 or C3 . The oxyanion thus formed is
less nucleophilic than the non-deprotonated hydroxyl at position
C6 [11] and is therefore more likely to bind to the AgNPs.
3.4. Particle sizing
TEM micrographs of capped and uncapped AgNPs showed them
to be nearly spherical in shape, with the average size decreasing
with increasing ␤-CD capping. DLS showed particles sizes of 6.2,
5.1 and 4.0 nm for ␤-CD-capped AgNPs (5, 10 and 20 mM, respectively) and 16.3 nm for the uncapped particle. The capped AgNPs
were much larger in size than the ␤-CD cavity (0.78 nm), indicating chemisorption interaction through the CD rim hydroxyls rather
than encapsulation.

3.5. Antibacterial activity
Most published AgNP antibacterial studies have used plate
counting [12] and agar diffusion methods. Fewer reports have
used the quantitative microtitre well dilution method. The
effect of ␤-CD capping on antibacterial activity was determined by comparing the percentage inhibition of bacterial
growth by uncapped AgNPs compared with that of capped
AgNPs (5, 10 and 20 mM ␤-CD) using a range of Ag concentrations (100, 50, 25, 12.5, 6.25 and 3.12 ppm) detailed in
Table 1.
␤-CD-capped AgNPs displayed signiﬁcantly (P < 0.05) greater
antibacterial activity against P. aeruginosa than uncapped AgNPs.
AgNPs capped with 20 mM and 10 mM ␤-CD had the strongest
activity of 99.2% and 97.3% inhibition, respectively, at 12.5 ppm
[Ag], whereas inhibition for AgNPs capped with 5 mM ␤-CD was
64.5% and for uncapped AgNPs was 13.9%. Both capped and
uncapped AgNPs with a [Ag] ≥25 ppm signiﬁcantly inhibited

Fig. 1. Growth curves of (a, b) Pseudomonas aeruginosa in the presence of 6.25 ppm [Ag] (a) and 3.12 ppm [Ag] (b), (c, d) Escherichia coli in the presence of 6.25 ppm [Ag] (c)
and 3.12 ppm [Ag] (d) and (e, f) Staphylococcus aureus in the presence of 6.25 ppm [Ag] (e) and 3.12 ppm [Ag] (f). (䊉) 20 mM ␤-cyclodextrin (␤-CD); () 10 mM ␤-CD; (×)
5 mM ␤-CD; () 0 mM ␤-CD; and () Ag/␤-CD-free control. OD, optical density.
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Fig. 2. Proposed bacterial interaction with ␤-cyclodextrin (␤-CD)-capped silver nanoparticles (AgNPs).

bacterial growth, whilst those with a [Ag] ≤6.25 ppm showed no
inhibition.
Escherichia coli was 97% inhibited at a [Ag] of ≥12.5 ppm. Below
this there was a variation in inhibition, with 20 mM ␤-CD-capped
AgNPs achieving 53.5% inhibition at 6.25 ppm, whereas uncapped
AgNPs showed only 22.8% inhibition.
Staphylococcus aureus was 97.1% inhibited by 20 mM ␤-CDcapped AgNPs at a [Ag] of 6.25 ppm compared with 59.5% inhibition
by uncapped AgNPs. Antibacterial activity was high (94.0% inhibition) even at a concentration of 10 mM ␤-CD. Similar ﬁndings were
obtained with a [Ag] of 3.12 ppm.
Antibacterial activity increased with corresponding rises in both
silver and cyclodextrin concentrations in all cases. Importantly, ␤CD alone showed no antibacterial activity.
Bacterial growth curves showed that the AgNPs delayed growth.
The 20 mM and 10 mM ␤-CD-capped AgNPs containing a [Ag]
of 6.25 ppm completely inhibited P. aeruginosa growth until 18 h
(Fig. 1a) compared with ca. 10 h for the uncapped AgNPs. Even
at a [Ag] of 3.12 ppm the 20 mM ␤-CD-capped AgNPs were more
effective than uncapped AgNPs (Fig. 1b). The 20 mM ␤-CD-capped
AgNPs at a [Ag] of 6.25 ppm exhibited superior antibacterial activity against E. coli compared with uncapped AgNPs, delaying growth
for 9 h versus 4.5 h (Fig. 1c). A similar trend was observed for the
10 mM and 5 mM ␤-CD-capped AgNPs. At a [Ag] of 6.25 ppm, AgNPs
capped with 20 mM and 10 mM ␤-CD delayed growth of S. aureus
for 17 h (Fig. 1e). At a [Ag] of 3.12 ppm capping doubled growth inhibition (Fig. 1f). Overall, the duration of the lag growth phase of the
test organisms when grown in the presence of AgNPs with different
[Ag] increased as the ␤-CD capping concentration increased.
The increased antibacterial activity of ␤-CD-capped AgNPs may
be attributed to a biodegradable capping agent forming smaller
nanoparticles without aggregation. These have a high surface-tovolume ratio and undergo a higher level of interaction with the
bacterial cell surface than the larger uncapped AgNPs, resulting in
a higher antibacterial activity.
It is proposed that intimate contact between AgNPs and organisms may enhance the transfer of Ag ions to the bacterial cell, whilst
bacterial degradation of the ␤-CD saccharide promotes the release
of silver ions (Fig. 2) [13]. Such interactions have been described as
Trojan-horse mechanisms and have been reported in the literature
where fetal bovine serum was used to improve AgNP efﬁcacy [14].
These results are in accordance with a previous report in which
AgNPs synthesised by disaccharides had higher antibacterial activities than those synthesised by monosaccharides [15].
4. Conclusion
In summary, there was an increase in the antibacterial activity
of ␤-CD-capped AgNPs compared with their uncapped equivalents.
This activity increased as the concentration of ␤-CD increased. Thus,
␤-CD capping can be used to achieve higher antibacterial efﬁcacies
at lower metal ion concentrations.
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